FREDUN PHARMACEUTICALS
|
The Current P/S Ratio of FREDUN PHARMACEUTICALS is 2.41.
| Share Price | ₹2,805.5 | Jul 01,2026 |
| Market Cap | ₹1,543.0 Cr | |
| Sales-TTM | ₹639.1 Cr | TTM-Consolidated Results |
| Price/Sales | 2.41x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of FREDUN PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,543.0 Cr] as on Jul 01,2026
(/) Sales [ ₹639.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 2.41x ]
Thus, for FREDUN PHARMACEUTICALS , the investors are currently willing to pay '2.41 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of FREDUN PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of FREDUN PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of FREDUN PHARMACEUTICALS
PS Ratio Performance Analysis for FREDUN PHARMACEUTICALS
- FREDUN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2026 to Mar2025 averaged 1.07x.
- FREDUN PHARMACEUTICALS 's operated at median p/e ratio of 1.44x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, FREDUN PHARMACEUTICALS 's p/e ratio peaked in Mar2026 at 1.44x.
- FREDUN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2025 of 0.7x.
How does FREDUN PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| FREDUN PHARMACEUTICALS | 639.1 | 2.41 | 1,543.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.66 | 447,704.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.45 | 173,684.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.24 | 157,093.0 |
| CIPLA LTD | 28,162.6 | 4.18 | 117,699.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.32 | 111,792.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.20 | 102,844.0 |
| LUPIN LTD | 27,958.0 | 3.92 | 109,576.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.07 | 110,608.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.65 | 89,344.7 |
| LAURUS LABS LTD | 6,812.9 | 11.84 | 80,691.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs FREDUN PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.41x |
| Max industry PS | 16.45x |
| Median industry PS | 4.18x |
| Average industry PS | 6.81x |
You may also like the below Video Courses